No Surprises Act Enforcement Act

HR4710, the No Surprises Act Enforcement Act, was introduced on July 23, 2025 by Rep. Murphy (R-NC-3) with 26 cosponsors. The bill amends the Public Health Service Act, ERISA, and the Internal Revenue Code to increase penalties for balance billing violations from $100 per day to $10,000 per individual failure. The bill is in early stage — referred to the Committees on Energy and Commerce, Education and Workforce, and Ways and Means. A companion bill (S2420) exists in the Senate. The bill does not authorize or appropriate any funding; it is a regulatory penalty increase with zero direct government spending. The money trail works through increased compliance costs and penalty exposure for health insurers that would be forced to pay higher fines for violations of existing balance billing protections. The mechanism is purely punitive — a cost increase for obligated parties (group health plans and insurers) with no offsetting revenue or subsidy. Structural losers are major health insurers: UnitedHealth Group ($UNH), Elevance Health ($ELV), Cigna Group ($CI), Humana ($HUM), and CVS Health ($CVS) via its Aetna subsidiary. These companies face a 100x increase in per-violation penalties, creating a new regulatory cost layer. The bill's early stage and bipartisan sponsorship (Republican lead, multiple Democratic cosponsors) suggest it has moderate legislative momentum but a long path to enactment. Real market data shows the opposite of what this bill would suggest: insurers have rallied sharply. ELV is at $371.34 (+7.71% 7-day, +26.84% 30-day), HUM at $243.84 (+13.29% 7-day, +40.63% 30-day), UNH at $366.68 (+3.31% 7-day, +35.51% 30-day), CVS at $83.05 (+6.54% 7-day, +15.62% 30-day), and CI at $284.66 (+3.27% 7-day, +6.71% 30-day). This rally is likely driven by other catalysts (earnings, Medicare Advantage rate updates) overwhelming the distant regulatory risk. Timeline: The bill must pass through three House committees before a floor vote, then reconcile with S2420. Given the current early stage with no committee hearings or markups, enactment in the 119th Congress (2025-2027) is uncertain. Real impact on insurer earnings is likely 2-3 years out even if passed.